IBDEI0GW ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22687,1,4,0)
 ;;=4^V11.1
 ;;^UTILITY(U,$J,358.3,22687,1,5,0)
 ;;=5^Personal H/O Affective Disorder
 ;;^UTILITY(U,$J,358.3,22687,2)
 ;;=^295250
 ;;^UTILITY(U,$J,358.3,22688,0)
 ;;=V15.89^^140^1262^52
 ;;^UTILITY(U,$J,358.3,22688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22688,1,4,0)
 ;;=4^V15.89
 ;;^UTILITY(U,$J,358.3,22688,1,5,0)
 ;;=5^Personal H/O Exposure To Persian Gulf Region
 ;;^UTILITY(U,$J,358.3,22688,2)
 ;;=^295291
 ;;^UTILITY(U,$J,358.3,22689,0)
 ;;=V11.3^^140^1262^45
 ;;^UTILITY(U,$J,358.3,22689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22689,1,4,0)
 ;;=4^V11.3
 ;;^UTILITY(U,$J,358.3,22689,1,5,0)
 ;;=5^Personal H/O Alcoholism
 ;;^UTILITY(U,$J,358.3,22689,2)
 ;;=^295252
 ;;^UTILITY(U,$J,358.3,22690,0)
 ;;=V15.07^^140^1262^46
 ;;^UTILITY(U,$J,358.3,22690,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22690,1,4,0)
 ;;=4^V15.07
 ;;^UTILITY(U,$J,358.3,22690,1,5,0)
 ;;=5^Personal H/O Allerlgy To Latex
 ;;^UTILITY(U,$J,358.3,22690,2)
 ;;=^322043
 ;;^UTILITY(U,$J,358.3,22691,0)
 ;;=V13.4^^140^1262^47
 ;;^UTILITY(U,$J,358.3,22691,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22691,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,22691,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,22691,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,22692,0)
 ;;=V12.72^^140^1262^48
 ;;^UTILITY(U,$J,358.3,22692,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22692,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,22692,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,22692,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,22693,0)
 ;;=V12.59^^140^1262^49
 ;;^UTILITY(U,$J,358.3,22693,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22693,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,22693,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,22693,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,22694,0)
 ;;=V45.81^^140^1262^50
 ;;^UTILITY(U,$J,358.3,22694,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22694,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,22694,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,22694,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,22695,0)
 ;;=V15.84^^140^1262^51
 ;;^UTILITY(U,$J,358.3,22695,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22695,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,22695,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,22695,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,22696,0)
 ;;=V15.85^^140^1262^57
 ;;^UTILITY(U,$J,358.3,22696,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22696,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,22696,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,22696,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,22697,0)
 ;;=V10.72^^140^1262^53
 ;;^UTILITY(U,$J,358.3,22697,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22697,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,22697,1,5,0)
 ;;=5^Personal H/O Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,22697,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,22698,0)
 ;;=V15.3^^140^1262^54
 ;;^UTILITY(U,$J,358.3,22698,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22698,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,22698,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,22698,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,22699,0)
 ;;=V10.61^^140^1262^29
 ;;^UTILITY(U,$J,358.3,22699,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22699,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,22699,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,22699,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,22700,0)
 ;;=V12.03^^140^1262^30
 ;;^UTILITY(U,$J,358.3,22700,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22700,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,22700,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,22700,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,22701,0)
 ;;=V10.82^^140^1262^31
 ;;^UTILITY(U,$J,358.3,22701,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22701,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,22701,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,22701,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,22702,0)
 ;;=V10.62^^140^1262^33
 ;;^UTILITY(U,$J,358.3,22702,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22702,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,22702,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,22702,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,22703,0)
 ;;=V10.63^^140^1262^32
 ;;^UTILITY(U,$J,358.3,22703,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22703,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,22703,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,22703,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,22704,0)
 ;;=V11.2^^140^1262^27
 ;;^UTILITY(U,$J,358.3,22704,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22704,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,22704,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,22704,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,22705,0)
 ;;=V15.81^^140^1262^43
 ;;^UTILITY(U,$J,358.3,22705,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22705,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,22705,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,22705,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,22706,0)
 ;;=V10.43^^140^1262^34
 ;;^UTILITY(U,$J,358.3,22706,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22706,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,22706,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,22706,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,22707,0)
 ;;=V12.71^^140^1262^35
 ;;^UTILITY(U,$J,358.3,22707,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22707,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,22707,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,22707,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,22708,0)
 ;;=V10.46^^140^1262^36
 ;;^UTILITY(U,$J,358.3,22708,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22708,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,22708,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,22708,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,22709,0)
 ;;=V11.0^^140^1262^37
 ;;^UTILITY(U,$J,358.3,22709,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22709,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,22709,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,22709,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,22710,0)
 ;;=V10.83^^140^1262^38
 ;;^UTILITY(U,$J,358.3,22710,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22710,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,22710,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,22710,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,22711,0)
 ;;=V15.1^^140^1262^39
 ;;^UTILITY(U,$J,358.3,22711,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22711,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,22711,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,22711,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,22712,0)
 ;;=V15.82^^140^1262^41
 ;;^UTILITY(U,$J,358.3,22712,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22712,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,22712,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,22712,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,22713,0)
 ;;=V12.01^^140^1262^40
 ;;^UTILITY(U,$J,358.3,22713,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22713,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,22713,1,5,0)
 ;;=5^Hx Of TB
 ;;^UTILITY(U,$J,358.3,22713,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,22714,0)
 ;;=V13.01^^140^1262^28
 ;;^UTILITY(U,$J,358.3,22714,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22714,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,22714,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,22714,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,22715,0)
 ;;=V12.51^^140^1262^42
 ;;^UTILITY(U,$J,358.3,22715,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22715,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,22715,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,22715,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,22716,0)
 ;;=V17.89^^140^1262^17
 ;;^UTILITY(U,$J,358.3,22716,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22716,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,22716,1,5,0)
 ;;=5^Family H/O Musculosk Dis
 ;;^UTILITY(U,$J,358.3,22716,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,22717,0)
 ;;=V12.54^^140^1262^26
 ;;^UTILITY(U,$J,358.3,22717,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22717,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,22717,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,22717,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,22718,0)
 ;;=V12.54^^140^1262^25
 ;;^UTILITY(U,$J,358.3,22718,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22718,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,22718,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,22718,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,22719,0)
 ;;=V15.88^^140^1262^23
 ;;^UTILITY(U,$J,358.3,22719,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22719,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,22719,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,22719,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,22720,0)
 ;;=V13.59^^140^1262^24
 ;;^UTILITY(U,$J,358.3,22720,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22720,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,22720,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,22720,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,22721,0)
 ;;=V12.04^^140^1262^55
 ;;^UTILITY(U,$J,358.3,22721,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22721,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,22721,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,22721,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,22722,0)
 ;;=V62.22^^140^1262^58
 ;;^UTILITY(U,$J,358.3,22722,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,22722,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,22722,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,22722,2)
 ;;=^336807
